Growing community of inventors

San Francisco, CA, United States of America

Mark Cancilla

Average Co-Inventor Count = 8.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 63

Mark CancillaMatthew G Stanton (4 patents)Mark CancillaDenise M Kenski (4 patents)Mark CancillaAarron T Willingham (4 patents)Mark CancillaJames J Cunningham (4 patents)Mark CancillaSteven M Stirdivant (4 patents)Mark CancillaHenry J Haringsma (4 patents)Mark CancillaWilliam Michael Flanagan (3 patents)Mark CancillaMichael W Flanagan (1 patent)Mark CancillaW Michael Flanagan (0 patent)Mark CancillaMark Cancilla (4 patents)Matthew G StantonMatthew G Stanton (69 patents)Denise M KenskiDenise M Kenski (10 patents)Aarron T WillinghamAarron T Willingham (9 patents)James J CunninghamJames J Cunningham (9 patents)Steven M StirdivantSteven M Stirdivant (9 patents)Henry J HaringsmaHenry J Haringsma (4 patents)William Michael FlanaganWilliam Michael Flanagan (9 patents)Michael W FlanaganMichael W Flanagan (1 patent)W Michael FlanaganW Michael Flanagan (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sirna Therapeutics, Inc. (4 from 138 patents)


4 patents:

1. 11932854 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

2. 11193126 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

3. 9970005 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

4. 9260471 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…